Profile data is unavailable for this security.
About the company
JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.
- Revenue in HKD (TTM)59.80bn
- Net income in HKD2.86bn
- Incorporated2018
- Employees3.18k
- LocationJD Health International Inc8th Floor, Building C No. 18 Kechuang 11, Yizhuang Economic and TechnologicalDevelopment Zone, Daxing DistrictBEIJING 101111ChinaCHN
- Websitehttps://ir.jdhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Welcia Holdings Co Ltd | 63.19bn | 1.12bn | 20.09bn | 15.29k | 17.68 | 1.57 | 8.55 | 0.3179 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Dashenlin Pharmaceutical Group Co Ltd | 29.05bn | 930.86m | 20.86bn | 45.47k | 22.47 | 2.77 | -- | 0.7179 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Yifeng Pharmacy Chain Co Ltd | 26.19bn | 1.67bn | 34.38bn | 39.65k | 20.58 | 3.06 | -- | 1.31 | 1.26 | 1.26 | 19.77 | 8.46 | 0.9734 | 4.00 | 14.51 | 603,225.00 | 6.72 | 6.93 | 12.76 | 12.47 | 38.47 | 38.73 | 6.90 | 6.71 | 0.8771 | 34.97 | 0.5237 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
| MatsukiyoCocokara & Co | 52.83bn | 2.66bn | 44.10bn | 13.37k | 16.67 | 1.67 | 11.50 | 0.8347 | 124.58 | 124.58 | 2,476.56 | 1,241.32 | 1.47 | 4.73 | 17.89 | 77,335,880.00 | 7.43 | 6.80 | 9.59 | 8.87 | 34.73 | 33.45 | 5.06 | 4.57 | 1.31 | -- | 0.0362 | 28.65 | 7.49 | 12.16 | 29.11 | 15.90 | 29.38 | 11.10 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 29.51bn | 964.80m | 64.37bn | 1.44k | 58.32 | 4.04 | 62.92 | 2.18 | 0.0686 | 0.0686 | 2.09 | 0.9892 | 1.34 | 12.07 | 39.74 | 20,567,430.00 | 4.37 | 1.89 | 5.88 | 2.54 | 21.81 | 21.67 | 3.27 | 1.49 | 2.41 | -- | 0.0056 | 0.00 | 0.9847 | 39.61 | 64.93 | -- | 30.14 | -- |
| JD Health International Inc | 59.80bn | 2.86bn | 87.58bn | 3.18k | 30.32 | 1.54 | 28.26 | 1.46 | 0.9052 | 0.9052 | 18.92 | 17.85 | 0.8519 | 7.84 | 157.40 | 19,180,360.00 | 4.07 | -8.61 | 5.16 | -10.70 | 22.57 | 22.76 | 4.78 | -10.39 | 3.35 | -- | 0.0042 | -- | 14.54 | 45.64 | 463.49 | 58.38 | 95.69 | -- |
Data as of Nov 05 2024. Currency figures normalised to JD Health International Inc's reporting currency: Hong Kong Dollar HKD
6.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Krane Funds Advisors LLCas of 03 Oct 2024 | 53.96m | 1.69% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 37.79m | 1.19% |
| Hang Seng Investment Management Ltd.as of 04 Oct 2024 | 20.05m | 0.63% |
| CSOP Asset Management Ltd.as of 03 Oct 2024 | 19.68m | 0.62% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 19.34m | 0.61% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 18.04m | 0.57% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 2024 | 16.18m | 0.51% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 13.69m | 0.43% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 11.74m | 0.37% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 11.57m | 0.36% |
More ▼
Data from 30 Jun 2024 - 10 Oct 2024Source: FactSet Research Systems Inc.
